These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


227 related items for PubMed ID: 22992258

  • 1. Development and validation of a cisplatin dose-ototoxicity model.
    Dille MF, Wilmington D, McMillan GP, Helt W, Fausti SA, Konrad-Martin D.
    J Am Acad Audiol; 2012; 23(7):510-21. PubMed ID: 22992258
    [Abstract] [Full Text] [Related]

  • 2. ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring.
    Dille MF, Ellingson RM, McMillan GP, Konrad-Martin D.
    J Am Acad Audiol; 2013 Oct; 24(9):769-81. PubMed ID: 24224985
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.
    Konrad-Martin D, James KE, Gordon JS, Reavis KM, Phillips DS, Bratt GW, Fausti SA.
    J Am Acad Audiol; 2010 May; 21(5):301-14; quiz 357. PubMed ID: 20569665
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A Store-and-Forward Tele-Audiology Solution to Promote Efficient Screenings for Ototoxicity during Cisplatin Cancer Treatment.
    Dille MF, McMillan GP, Helt WJ, Konrad-Martin D, Jacobs P.
    J Am Acad Audiol; 2015 Oct; 26(9):750-60. PubMed ID: 26415968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes.
    McMillan GP, Konrad-Martin D, Dille MF.
    Int J Audiol; 2012 Sep; 51(9):689-96. PubMed ID: 22676700
    [Abstract] [Full Text] [Related]

  • 10. Proposed comprehensive ototoxicity monitoring program for VA healthcare (COMP-VA).
    Konrad-Martin D, Reavis KM, McMillan G, Helt WJ, Dille M.
    J Rehabil Res Dev; 2014 Sep; 51(1):81-100. PubMed ID: 24805896
    [Abstract] [Full Text] [Related]

  • 11. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
    Crabb SJ, Martin K, Abab J, Ratcliffe I, Thornton R, Lineton B, Ellis M, Moody R, Stanton L, Galanopoulou A, Maishman T, Geldart T, Bayne M, Davies J, Lamb C, Popat S, Joffe JK, Nutting C, Chester J, Hartley A, Thomas G, Ottensmeier C, Huddart R, King E.
    Eur J Cancer; 2017 Dec; 87():75-83. PubMed ID: 29128692
    [Abstract] [Full Text] [Related]

  • 12. The importance of high-tone audiometry in monitoring for ototoxicity.
    Tange RA, Dreschler WA, van der Hulst RJ.
    Arch Otorhinolaryngol; 1985 Dec; 242(1):77-81. PubMed ID: 3899068
    [Abstract] [Full Text] [Related]

  • 13. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
    Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Oncology; 2006 Dec; 70(3):177-84. PubMed ID: 16757924
    [Abstract] [Full Text] [Related]

  • 14. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G.
    Int J Pediatr Otorhinolaryngol; 2001 May 31; 59(1):47-57. PubMed ID: 11376818
    [Abstract] [Full Text] [Related]

  • 15. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.
    Waters GS, Ahmad M, Katsarkas A, Stanimir G, McKay J.
    Ear Hear; 1991 Apr 31; 12(2):91-102. PubMed ID: 2065844
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between cisplatin administration and the development of ototoxicity.
    Rademaker-Lakhai JM, Crul M, Zuur L, Baas P, Beijnen JH, Simis YJ, van Zandwijk N, Schellens JH.
    J Clin Oncol; 2006 Feb 20; 24(6):918-24. PubMed ID: 16484702
    [Abstract] [Full Text] [Related]

  • 19. Ototoxicity monitoring in children treated with platinum chemotherapy.
    Brooks B, Knight K.
    Int J Audiol; 2018 Sep 20; 57(sup4):S34-S40. PubMed ID: 28737048
    [Abstract] [Full Text] [Related]

  • 20. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
    Biró K.
    Magy Onkol; 2009 Sep 20; 53(3):279-83. PubMed ID: 19793694
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.